The panels assess genes with strong disease links and clinical management guidelines, but the firm offers limited-evidence genes as an add-on option.
WASHINGTON--The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC) announced key ...
The panels assess genes with strong disease links and clinical management guidelines, but the firm offers limited-evidence genes as an add-on option.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback